Elevation Oncology Inc
Change company Symbol lookup
Select an option...
ELEV Elevation Oncology Inc
FRZA Forza X1 Inc
SIEN Sientra Inc
PMGM Priveterra Acquisition Corp
NVFY Nova LifeStyle Inc
GGIFF Garibaldi Resources Corp
MIGI Mawson Infrastructure Group Inc
GTIM Good Times Restaurants Inc
BENF Avalon Acquisition Inc
SOS Sos Ltd

Health Care : Biotechnology |
Company profile

Elevation Oncology, Inc. is an oncology company. The Company is focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. Its lead product candidate, EO-3021 (SYSA1801 or CPO102), is an antibody-drug conjugate (ADC) designed to target Claudin 18.2, a clinically validated molecular target, which can selectively deliver a cytotoxic payload directly to cancer cells expressing Claudin 18.2. Claudin 18.2 is expressed across several solid tumor types, including many gastrointestinal cancers such as gastric, gastroesophageal junction and pancreatic cancer. Claudin 18.2 is also expressed in ovarian cancer, non-small cell lung cancer (NSCLC) and other solid tumors. The Company is exploring opportunities through new or existing partnerships and business development opportunities to expand its novel oncology pipeline.

Day's Change
-1.07 (-37.94%)
B/A Size
Day's High
Day's Low
(Heavy Day)

Today's volume of 5,916,500 shares is on pace to be much greater than ELEV's 10-day average volume of 8,118,558 shares.


Uber and Lyft drivers receive a delayed raise after three strikes and a lawsuit in New York

8:20 am ET March 9, 2023 (MarketWatch)

By Levi Sumagaysay

Commission approves rate increase of nearly 9% in fight that has been heated since last year, when companies instituted fuel surcharge

After three driver strikes and a lawsuit, the New York City Taxi and Limousine Commission on Wednesday approved a raise in rates for tens of thousands of ride-hailing drivers that should begin next week.

Drivers for Uber Technologies Inc. (UBER) and Lyft Inc. (LYFT) had been fighting to increase their pay since last year, when they complained that the ride-hailing companies had enacted fuel surcharges in response to the rising costs of fuel in other places but not New York City. The Taxi and Limousine Commission in November proposed a pay increase for drivers -- in addition to scheduled annual increases -- but Uber sued to block it and a judge agreed that the commission had not included its calculations to show justification for the increase.

According to calculations included in the commission's final proposal, the drivers will receive an 8.78% increase from the rates that were in effect from March 2022 through January 2023, starting Monday.

"I'm excited that we have come to a rule that has worked for everyone," said David Do, commissioner and chair of the commission, during a meeting Wednesday, which was live-streamed.

"We applaud the TLC for heeding the calls of our strike to make the raises a reality," New York Taxi Workers Alliance Executive Director Bhairavi Desai said in a statement Wednesday, though she noted that the raises -- which are not retroactive -- should have been effective in December. "Today, we celebrate our victory, and, today, we keep fighting for more."

Representatives for Uber and Lyft expressed support for the outcome.

"The TLC's proposal includes changes that will ensure fairer competition within our industry," said CJ Macklin, spokesperson for Lyft. "We are appreciative of them listening to our concerns and look forward to continued engagement on ways we can improve ride-share overall."

"The roughly 2.25% one-time increase is more reasonable than what was previously proposed," said Freddi Goldstein, spokesperson for Uber, referring to the percentage increase in pay that the drivers will get from what they are currently receiving. The proposed increase in November would have been higher, Goldstein noted.

-Levi Sumagaysay


This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.


(END) Dow Jones Newswires

March 09, 2023 08:20 ET (13:20 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.